ESSA Pharma Inc.
NASDAQ: EPIX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- David Ross Parkinson
- Employees
- 35
- Headquarters
- Vancouver, Canada
- IPO year
- 2015
- Market cap
- $9.5M
- Website
- https://www.essapharma.com
Loading EPIX…
Loading profile data…Frequently asked questions about EPIX
What does ESSA Pharma Inc. (EPIX) do?
ESSA Pharma Inc. (EPIX) functions as a clinical-stage pharmaceutical firm, concentrating its efforts on developing innovative and exclusive therapies designed to combat prostate cancer. The company's primary drug candidate is EPI-7386, an oral treatment presently undergoing Phase I clinical trials. This investigational compound is intended for i...
Where does EPIX trade?
ESSA Pharma Inc. (EPIX) trades on the NASDAQ Capital Market.
What sector is EPIX in?
ESSA Pharma Inc. (EPIX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of ESSA Pharma Inc.?
David Ross Parkinson is the chief executive officer of ESSA Pharma Inc. (EPIX).
Where is ESSA Pharma Inc. headquartered?
ESSA Pharma Inc. is headquartered in Canada.
Does EPIX pay a dividend?
Yes — ESSA Pharma Inc. (EPIX) paid a trailing twelve-month dividend of USD 1.69 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did EPIX go public?
ESSA Pharma Inc. (EPIX) completed its initial public offering in 2015.